Advertisement Osteotech and BioHorizons sign distribution agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Osteotech and BioHorizons sign distribution agreement

Osteotech has signed an exclusive distribution agreement with BioHorizons, effective as of April 1, 2008, under which BioHorizons will market Osteotech's bone regeneration products to the dental market in 29 countries in Europe, the Middle East, Latin America and Asia.

Osteotech and BioHorizons previously entered into an agreement for BioHorizons to distribute Osteotech’s products to the US dental market in 2000.

Sam Owusu-Akyaw, Osteotech’s president and CEO, said: “We believe our bone regeneration products are the perfect solution for the new bone grafting procedures being developed to replace missing or extracted teeth with dental implants or as support for dentures, crowns and bridges.”